Back to All NewsProfound for the Treatment of Cellulite in 2017
Posted By American Med Spa Association, Wednesday, December 28, 2016
Share
In November, Syneron Medical Ltd. announced that it received a new FDA 510(k) clearance of its minimally invasive, fractional radiofrequency (RF) microneedling device Profound.
The new indication is for using the device with the 75o SubQ handpiece and cartridge to improve the appearance of cellulite.
“Profound is the first and most effective single minimally invasive treatment for cellulite that provides a meaningful improvement,” Macrene Alexiades, M.D., PhD, tells Cosmetic Surgery Times.
Dr. Alexiades, who is director and president of the Dermatology & Laser Surgery Center of New York, was an investigator of a recent multi-center clinical study of Profound, which examined and analyzed the dimples and/or undulation irregularities in the thighs of 50 women with Fitzpatrick skin types I – III.
Read more at Cosmetic Surgery Times >>
The new indication is for using the device with the 75o SubQ handpiece and cartridge to improve the appearance of cellulite.
“Profound is the first and most effective single minimally invasive treatment for cellulite that provides a meaningful improvement,” Macrene Alexiades, M.D., PhD, tells Cosmetic Surgery Times.
Dr. Alexiades, who is director and president of the Dermatology & Laser Surgery Center of New York, was an investigator of a recent multi-center clinical study of Profound, which examined and analyzed the dimples and/or undulation irregularities in the thighs of 50 women with Fitzpatrick skin types I – III.
Read more at Cosmetic Surgery Times >>
